Late-onset @entity6126 among old and middle-aged males with XXXX in Polish population.

@entity1 @entity13897 @entity323 @entity6 @entity5710 @entity6126
UNASSIGNED: Abstract Objectives: Around 40% of @entity6 @entity1 have lowered testosterone and symptoms of @entity6126 but the prevalence of @entity6126 among @entity5710 @entity1 is unknown. The aim of this study was to investigate the prevalence of late-onset @entity6126 (LOH) in population of Polish @entity1 with @entity5710 . Methods: This study was performed in 196 @entity5710 @entity1 and in 184 normoglycemic, control group. @entity5710 was defined as impaired fasting @entity13897 , @entity13897 and/or HbA1c 5.7-6.4%. LOH was defined as low libido, diminished frequency of morning erections and @entity323 in @entity1 with total testosterone <12   nmol/l. Results: Total testosterone (TT) level in @entity5710 group was 11.78        1.76 and 16.37        1.6   nmol/l in control group (p   <   0.001). LOH was diagnosed in 30% @entity5710 @entity1 and in 13.6% control @entity1 . There were negative relationships between calculated free testosterone (cFT) and HbA1c (r   =   -0.3856; p   <   0.005). In @entity5710 group, TT and cFT levels were lower in @entity1 with @entity13897 than impaired fasting @entity13897 (p   <   0.05 and p   <   0.02, respectively). We showed inverse relationships between IIEF-5 score and cFT (r   =   -0.414, p   <   0.005) and between IIEF-5 and HbA1c (r   =   -0.395, p   <   0.002). Conclusions: In population of Polish @entity1 with @entity5710 we observed high prevalence of LOH. Routine testosterone screening should be performed in all @entity5710 @entity1 .
